UVEITIS INA RHEUMATOLOGISTS PRACTICE: A ROLE OF TUMOR NECROSIS FACTOR-а INHIBITORS
Uveitis frequently develops in patients with ankylosing spondylitis (AS) and other autoimmune diseases. It is occasionally characterized by a severe recurrent course and untreatable with systemic glucocorticoids (GC) and standard immunosuppressive agents. The results of (mainly small) clinical trial...
Saved in:
| Main Author: | Sergey Valentinovich Moiseyev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2009-12-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/262 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early versus late initiation of infliximab for refractory uveitis in a cohort of Egyptian BD patients
by: Mariam R Fadel, et al.
Published: (2024-08-01) -
Perspectives for uveitis treatment in rheumatic diseases
by: Alla Aleksandrovna Godzenko, et al.
Published: (2011-06-01) -
Outcome of cataract surgery in juvenile idiopathic arthritis-associated uveitis under two different biological regimens
by: Mariam R Fadel, et al.
Published: (2024-10-01) -
THE PROBLEMS OF THE SAFETY OF THERAPY WITH TUMOR NECROSIS FACTOR-а INHIBITORS
by: Dmitry Evgenyevich Karateyev
Published: (2009-09-01) -
Therapeutic drug monitoring and neutralizing anti-drug antibody detection to optimize TNF-alpha inhibitor treatment for uveitis
by: Howard C. Chen, et al.
Published: (2025-01-01)